Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Syndax Pharmaceuticals Inc (SNDX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011233
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the treatment of advanced hormone receptor positive and human epidermal growth factor receptor 2 negative breast cancer. Its product candidate, entinostat, also intended for the treatment of non-small cell lung cancer and melanoma, ovarian cancer and other indications. The company also develops SNDX-6352, a monoclonal antibody that targets the CSF-1 receptor.Syndax is headquartered in Waltham, Massachusetts, the US.

Syndax Pharmaceuticals Inc (SNDX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Syndax Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Syndax Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Syndax Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Syndax Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Syndax Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Syndax Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Partnerships 10
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems 10
Equity Offering 11
Syndax Pharma to Raise USD25 Million in Private Placement of Shares 11
Syndax Pharma Raises USD52.34 Million in Public Offering of Shares 12
Syndax Pharmaceuticals Inc – Key Competitors 14
Syndax Pharmaceuticals Inc – Key Employees 15
Syndax Pharmaceuticals Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Nov 07, 2017: Syndax Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Clinical and Business Update 17
Aug 10, 2017: Syndax Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Clinical and Business Update 19
May 08, 2017: Syndax Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Clinical and Business Update 21
Mar 02, 2017: Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update 23
Nov 10, 2016: Syndax Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update 25
Aug 09, 2016: Syndax Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update 27
May 16, 2016: Syndax Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update Following IPO 29
Corporate Communications 31
Apr 04, 2017: Syndax Pharmaceuticals Adds Biopharmaceutical Industry Leader Keith A. Katkin to Board of Directors 31
Feb 09, 2017: Syndax Appoints Richard P. Shea as Chief Financial Officer 32
Jan 31, 2017: Syndax Appoints Lisa M. Coussens, Ph.D., to Scientific Advisory Board 33
Jan 05, 2017: Syndax Adds Global Pharmaceutical Business Veteran to Board of Directors 34
Jul 27, 2016: Syndax Appoints Leading Experts to Scientific Advisory Board 35
Jan 20, 2016: Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financial Officer 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Syndax Pharmaceuticals Inc, Medical Equipment, Key Facts, 2016 2
Syndax Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Syndax Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Syndax Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Syndax Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Syndax Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Syndax Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Syndax Pharma Enters Into Co-Development Agreement With Ventana Medical Systems 10
Syndax Pharma to Raise USD25 Million in Private Placement of Shares 11
Syndax Pharma Raises USD52.34 Million in Public Offering of Shares 12
Syndax Pharmaceuticals Inc, Key Competitors 14
Syndax Pharmaceuticals Inc, Key Employees 15
Syndax Pharmaceuticals Inc, Other Locations 16

★海外企業調査レポート[Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pinnacle Entertainment Inc:企業のM&A・事業提携・投資動向
    Pinnacle Entertainment Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pinnacle Entertainment Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Greenphire Inc-医療機器分野:企業M&A・提携分析
    Summary Greenphire Inc (Greenphire) is a provider of clinical trial payment solutions which offers site payments and paitent reimbursement. Its product portfolio includes eClinicalGPS and ClinCard. The eClinicalGPS is a global site that facilitates accurate payment calculation, manages complex payme …
  • EnerDel Inc:企業の戦略的SWOT分析
    EnerDel Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Crown Van Gelder N.V.:企業の戦略・SWOT・財務分析
    Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report Summary Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Analog Devices, Inc.:企業の戦略・SWOT・財務情報
    Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GeoPark Ltd (GPRK):石油・ガス:M&Aディール及び事業提携情報
    Summary GeoPark Ltd (GeoPark) is an oil and gas exploration and production company that explores, develops and produces upstream oil and gas in Latin America. The company operates various blocks such as Colombia blocks, Chile blocks, Brazil blocks, Peru blocks and Argentina blocks. Its Colombia bloc …
  • NCC Ltd (NCC):企業の財務・戦略的SWOT分析
    NCC Ltd (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Telkom SA SOC Limited:企業の戦略・SWOT・財務情報
    Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report Summary Telkom SA SOC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Merge Healthcare Inc:医療機器:M&Aディール及び事業提携情報
    Summary Merge Healthcare Inc (Merge Technologies), a subsidiary of International Business Machines Corp, is a medical technology company that offers advanced solutions specifically designed for healthcare. The company's solutions include cardiology, orthopedics, interoperability, radiology, eye care …
  • Camargo Correa Sa:企業の戦略・SWOT・財務分析
    Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report Summary Camargo Correa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Trader Joe’s Company:企業の戦略・SWOT・財務情報
    Trader Joe's Company - Strategy, SWOT and Corporate Finance Report Summary Trader Joe's Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tata Motors Ltd (TATAMOTORS):企業の財務・戦略的SWOT分析
    Tata Motors Ltd (TATAMOTORS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Tesco Plc (TSCO):企業の財務・戦略的SWOT分析
    Tesco Plc (TSCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Materialise NV (MTLS):企業の財務・戦略的SWOT分析
    Materialise NV (MTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Galen Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd, is a pharmaceutical company. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angina, constipa …
  • NTT DOCOMO Inc:企業の戦略・SWOT・財務分析
    NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Korea East-West Power Co Ltd:企業の戦略的SWOT分析
    Korea East-West Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆